Safety and Immunogenicity of Oral Inactivated Whole-Cell Helicobacter pylori Vaccine with Adjuvant among Volunteers with or without Subclinical Infection

Podobne zapisy

• Protection against Experimental Helicobacter pylori Infection after Immunization with Inactivated H. pylori Whole-Cell Vaccines
  od: Raghavan, S., i wsp.
  Wydane: (2002)
• Safety and Immunogenicity of Increasing Doses of a Clostridium difficile Toxoid Vaccine Administered to Healthy Adults
  od: Kotloff, Karen L., i wsp.
  Wydane: (2001)
• Inactivation of Helicobacter pylori by chlorination.
  od: Johnson, C H, i wsp.
  Wydane: (1997)
• Immunogenicity of Recombinant Helicobacter pylori Urease B Administered by Various Routes and with Different Adjuvants
  od: Bégué, Rodolfo E, i wsp.
  Wydane: (2009)
• Therapeutic Vaccination against Helicobacter pylori in the Beagle Dog Experimental Model: Safety, Immunogenicity, and Efficacy
  od: Rossi, Giacomo, i wsp.
  Wydane: (2004)